Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Sentara Health is piloting GW RhythmX's AI precision care platform with 30 physicians across two markets to bring real-time, patient-specific clinical recommendations directly into primary care workflows. The 90-day pilot goes beyond ambient documentation tools, pulling together clinical, payer, and social determinants data to guide next-best-action decisions. If successful, the health system plans to expand the technology across primary care and other ambulatory settings.
Sentara Health is taking AI beyond administrative tasks and putting it to work during actual patient encounters. The not-for-profit health system — which operates 12 hospitals and over 400 care sites in Virginia and North Carolina — has launched a 90-day pilot with GW RhythmX, testing an AI precision care platform with 30 physicians and advanced practice providers in family and internal medicine across two markets.
The platform isn't just another ambient scribe. It synthesizes patient history, evidence-based guidelines, care gaps, social determinants of health, payer requirements, and formulary data to deliver hyper-personalized, next-best-action recommendations in real time during the clinical encounter. The goal: help primary care teams manage increasingly complex patients without burning out clinicians or flooding specialists with unnecessary referrals. The pilot is part of Sentara's broader "care model redesign" — a team-based ambulatory care strategy pairing physicians, APPs, nurses, pharmacists, and care managers with AI and telehealth tools to expand capacity without expanding headcount.
By the Numbers:
Why it matters: Primary care is under enormous strain — aging populations, rising complexity, and a shrinking workforce. AI tools that go beyond note-taking to actively support clinical decision-making could be a meaningful lever for health systems trying to do more with less, while keeping human clinicians firmly in the driver's seat.
